References
- Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D (2001). Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett, 495, 56-60. https://doi.org/10.1016/S0014-5793(01)02366-3
- Brenner W, Färber G, Herget T, et al (2002). Loss of tumor suppressor protein PTEN during renal carcinogenesis. Int J Canaer, 99, 53-7. https://doi.org/10.1002/ijc.10303
- Feng Y, Tian ZM, Wan MX, Zheng ZB (2008). Low intensity ultrasound-induced apoptosis in human gastric carcinoma cells. World J Gastroenterol, 14, 4873-9. https://doi.org/10.3748/wjg.14.4873
- Gangar SC, Koul A (2008). Histochemical, ultrastructural, and biochemical evidences for Azadirachta indica-induced apoptosis in benzo(a)pyrene-induced murine forestomach tumors. J Environ Pathof Toxicol Oncol, 27, 219-32. https://doi.org/10.1615/JEnvironPatholToxicolOncol.v27.i3.60
- Hager M (2007). PTEN expression in renal cell carcinoma and progonosis. Pathology, 39, 482-5. https://doi.org/10.1080/00313020701570012
- Huang J, Kontos CD (2002). Moddulates vaseular endotheliad growth factor-mediated signaling and angiogenic effects. J Biol Chem, 277, 10760-6. https://doi.org/10.1074/jbc.M110219200
- Ka H, Hunt JS (2003). Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol, 163, 413-22. https://doi.org/10.1016/S0002-9440(10)63671-1
- Kasof GM, Gomes BC (2001). Livin, a novel inhibitor of apoptosis protein Family member. J Biol Chem, 276, 3238-46. https://doi.org/10.1074/jbc.M003670200
-
Li DM, Sun H (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosin ephosphates regulated by transforming growth factor
${\beta}$ . Cancer Res, 57, 2124-9. - Li RH (2009). Livin and PTEN in colorectal cancer tissues and its significance. Chin J integrated traditional and Western Med, 16, 247-8.
- Nachmias B, Mizrahi S, Elmalech M, et al (2007). Manipulation of NK cytotoxicitv by the IAP family member Livin. Eur J Immunol, 37, 3467-6. https://doi.org/10.1002/eji.200636600
- Ni JH, Xin J, Wu BC, Xin MH, Wu WF (2011). Livin and PTEN in renal cell carcinoma and its clinical significance. Practical J Cancer, 26, 42-4.
- Rasheed BK, Stenzel TT, Melendon RE, et al (1997). PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res, 57, 4187-90.
- Sui CD, Miao B (2009). PTEN and Livin in tongue squamous cell carcinoma and its clinical significance. Heilongjiang Pharmaceutical Science, 32, 26-7.
- Sun CH, Chang YH, Pan CC (2011). Activation of the p13k/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder. Hisopathologh, 58, 1054-63. https://doi.org/10.1111/j.1365-2559.2011.03856.x
- Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N (2004). Expression of survivin mRNA and Livin mRNA in non-small-cell lung cancer. Lung Cancer, 46, 299-304. https://doi.org/10.1016/j.lungcan.2004.05.002
- Trotman LC, Wang X, A1imonti A, et al (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell, 128, 141-56. https://doi.org/10.1016/j.cell.2006.11.040
- Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM (2000). LIVIN, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol, 10, 1359-66. https://doi.org/10.1016/S0960-9822(00)00781-8
- Xu ST, Yan CY, Huang YH, Ding X (2010). Research on expression of livin in human renal cell carcinoma. Med J West China, 22, 217-9.
- Zhang Q, Gao Y, Wang XL, et al (2010). In esophageal squamous cell carcinoma tissue PTEN, Livin changes in protein expression and significance. Shandong Med J, 50, 52-3.
- Zhao Y, Deng X, Wang Q (2009). Livin, Smac/DIABLO in stomach tissue PTEN and expression and the correlation and gastric cancer. World Chinese J Digestol, 17, 1303-11.
Cited by
- Expression and Clinical Significance of Livin Protein in Hepatocellular Carcinoma vol.35, pp.1875-8630, 2013, https://doi.org/10.1155/2013/781740
- Association of the PTEN IVS4 (rs3830675) Gene Polymorphism with Reduced Risk of Cancer: Evidence from a Meta-analysis vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.897
- MicroRNA-22 is downregulated in clear cell renal cell carcinoma, and inhibits cell growth, migration and invasion by targeting PTEN vol.13, pp.6, 2016, https://doi.org/10.3892/mmr.2016.5101